Educational article
Antifungal agents
Antifungals have targets distinct from most antibacterial agents. Azoles affect ergosterol synthesis, polyenes interact with membranes and echinocandins affect cell-wall β-glucan synthesis. Yeasts and moulds differ in…
Overview
Antifungals have targets distinct from most antibacterial agents. Azoles affect ergosterol synthesis, polyenes interact with membranes and echinocandins affect cell-wall β-glucan synthesis. Yeasts and moulds differ in susceptibility spectra.
Biology and practical meaning
Target changes, efflux and other mechanisms produce resistance. Species identification is important, including for C. auris. Fungal MICs require specialised current tables; bacterial breakpoints and interpretation rules do not apply.
Spectrum, exposure and AST
Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.
Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.
S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.
Teaching example: from finding to conclusion
Teaching example: a yeast MIC is compared with a bacterial table. The measurement exists, but the wrong standard was selected. Fungal methods and organism-specific breakpoints are assessed separately.
Some pairs have an epidemiological cutoff without a clinical category. It informs acquired-mechanism assessment without automatically creating S or R. Identification is particularly important for unusual resistance and possible C. auris, and interpretation remains traceable.
Sources
Read next
Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.